Left Atrial Volume Quantified by MSCT Predicts Emergency Hospitalizations for AF and Arrhythmia Recurrence after Catheter Ablation

1 Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of AF: the Task Force for the Management of AF of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429. doi: 10.1093/eurheartj/ehq278. Search in Google Scholar

2 de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent AF clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–731. doi: 10.1016/j. jacc.2009.11.040. Search in Google Scholar

3 Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of AF developed in collaboration with EACTS. Eur Heart J. 2016;50:5:e1–e88. doi: 10.1093/ejcts/ezw313. Search in Google Scholar

4 Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic AF: the Framingham Heart Study. Circulation. 1994;89:724–730. doi: 10.1161/01.cir.89.2.724. Search in Google Scholar

5 Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients ≥65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005;96:832–836. doi: 10.1016/j.amjcard.2005.05.031. Search in Google Scholar

6 Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835–841. Search in Google Scholar

7 Su G, Cao H, Xu S, et al. Left Atrial Enlargement in the Early Stage of Hypertensive Heart Disease: A Common But Ignored Condition. The Journal of Clinical Hypertension. 2014;16:3:192-197. doi: 10.1111/jch.12282. Search in Google Scholar

8 Guglielmo M, Baggiano A, Muscogiuri G, et al. Multimodality imaging of left atrium in patients with AF. Journal of Cardiovascular Computed Tomography. 2019;6:340-346. doi: 10.1016/j.jcct.2019.03.005. Search in Google Scholar

9 Mahabadi AA, Samy B, Seneviratne SK, et al. Quantitative assessment of left atrial volume by electrocardiographic-gated contrast-enhanced multidetector computed tomography. J Cardiovasc Comput Tomogr. 2009;3:80–87. doi: 10.1016/j. jcct.2009.02.002. Search in Google Scholar

10 Christiaens L, Lequeux B, Ardilouze P, et al. A new method for measurement of left atrial volumes using 64-slice spiral computed tomography: comparison with two-dimensional echocardiographic techniques. Int J Cardiol. 2009;131:217–224. doi: 10.1016/j.ijcard.2007.10.020. Search in Google Scholar

11 Avelar E, Durst R, Rosito GA, et al. Comparison of the accuracy of multidetector computed tomography versus two-dimensional echocardiography to measure left atrial volume. Am J Cardiol. 2010;106:104–109. doi: 10.1016/j.amjcard.2010.02.021. Search in Google Scholar

12 Blum S, Meyre P, Aeschbacher S, Berger S, et al. Incidence and Predictors of AF Progression: A Systematic Review and Meta-Analysis. Heart Rhythm. 2018;16:4:502–510. doi: 10.1016/j. hrthm.2018.10.022. Search in Google Scholar

13 Nicolaou VN, Papadakis JE, Karatzis EN, et al. Impact of the metabolic syndrome on atrial size in patients with new-onset AF. Angiology. 2007;58:21–25. doi: 10.1177/0003319706297913. Search in Google Scholar

14 Ayer JG, Almafragy HS, Patel AA, et al. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008;17:19–24. doi: 10.1016/j.hlc.2007.04.006. Search in Google Scholar

15 Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024. doi: 10.1161/01. str.30.10.2019. Search in Google Scholar

16 Lemire F, Tajik AJ, Hagler DJ. Asymmetric left atrial enlargement; an echocardiographic observation. Chest. 1976;69:779–781. doi: 10.1378/chest.69.6.779. Search in Google Scholar

17 Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–832. doi: 10.1016/s0002-9149(99)00446-4. Search in Google Scholar

18 Russo C, Jin Z, Homma S, et al. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98:813–820. doi: 10.1136/heartjnl-2011-301388. Search in Google Scholar

19 Lee JS, Shim CY, Wi J, et al. Left ventricular diastolic function is closely associated with mechanical function of the left atrium in patients with paroxysmal AF. Circ J. 2013;77:697–704. doi: 10.1253/circj.cj-12-1009. Search in Google Scholar

20 Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy data from the Acorn trial. Am Heart J. 2009;157:762–710. doi: 10.1016/j.ahj.2008.12.018. Search in Google Scholar

21 Cheng YJ, Church TS, Kimball TE, et al. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease. Am J Cardiol. 2003;92:498–503. doi: 10.1016/s0002-9149(03)00714-8. Search in Google Scholar

22 Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with AF: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943–959. doi: 10.1016/j.jacc.2015.06.1313. Search in Google Scholar

23 O’Neal WT, Efird JT, Qureshi WT, et al. Coronary artery calcium progression and AF: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2015;8:e003786. doi: 10.1161/CIRCIMAGING.115.003786. Search in Google Scholar

24 Pan NH, Tsao HM, Chang NC, Lee CM, Chen YJ, Chen SA. Dilated left atrium and pulmonary veins in patients with calcified coronary artery: a potential contributor to the genesis of AF. J Cardiovasc Electrophysiol. 2009;20:153–158. doi: 10.1111/j.1540-8167.2008.01290.x. Search in Google Scholar

25 Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during AF. Cardiovasc Res. 2002;54:230–246. doi: 10.1016/s0008-6363(02)00258-4. Search in Google Scholar

26 Avitall B, Bi J, Mykytsey A, Chicos A. Atrial and ventricular fibrosis induced by AF: evidence to support early rhythm control. Heart Rhythm. 2008;5:839–845. doi: 10.1016/j. hrthm.2008.02.042. Search in Google Scholar

27 Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of AF. Nat Rev Cardiol. 2015;12:230–243. doi: 10.1038/nrcardio.2015.2. Search in Google Scholar

28 O’Neill MD, Jaïs P, Takahashi Y, et al. The stepwise ablation approach for chronic AF--evidence for a cumulative effect. J Interv Card Electrophysiol. 2006;16:153–167. doi: 10.1007/s10840-006-9045-1. Search in Google Scholar

29 Blîndu E, Korodi S, Bordi L, Kovács I, Benedek I. Epicardial Fat Volume as a New Imaging-Based Feature Associated with Risk of Recurrence after Pulmonary Veins Ablation in AF. Journal of Interdisciplinary Medicine. 2020;5:2:64–70. doi: 10.2478/jim-2020-0012. Search in Google Scholar

30 Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with AF and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46:1729–1736. doi: 10.1016/j.jacc.2005.06.077. Search in Google Scholar

31 Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident AF 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34:1061–1067. doi: 10.1093/eurheartj/ehs469. Search in Google Scholar

32 Chen SC, Chang JM, Tsai YC, et al. Left atrial diameter and albumin with renal outcomes in chronic kidney disease. Int J Med Sci. 2013;10:575–584. doi: 10.7150/ijms.5845. Search in Google Scholar

33 Santhanakrishnan R, Wang N, Larson MG, et al. AF begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133:484–492. doi: 10.1161/CIRCULATIONAHA.115.018614. Search in Google Scholar

34 Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal AF: the APAF study. J Am Coll Cardiol. 2006;48:2340–2347. doi: 10.1016/j. jacc.2006.08.037. Search in Google Scholar

35 Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for AF: the A4 study. Circulation. 2008;118:2498–2505. doi: 10.1161/CIRCULATIONAHA.108.772582. Search in Google Scholar

36 Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal AF: a randomized controlled trial. JAMA. 2010;303:333–340. doi: 10.1001/jama.2009.2029. Search in Google Scholar

37 Marrouche NF, Brachmann J, Andresen D, Siebels et al. CASTLE-AF Investigators. Catheter ablation for AF with heart failure. N Engl J Med. 2018;378:417–427. doi: 10.1056/NEJMoa1707855. Search in Google Scholar

38 Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent AF in heart failure. J Am Coll Cardiol. 2013;61:1894–1903. doi: 10.1016/j.jacc.2013.01.069. Search in Google Scholar

39 Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of AF in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–38. doi: 10.1161/CIRCEP.113.000806. Search in Google Scholar

40 Siontis KC, Noseworthy PA. FIRE or ICE for paroxysmal AF?—perspectives from the largest randomized evaluation of cryoballoon and radiofrequency ablation to date. J Thorac Dis. 2017;9:3:419-422. doi: 10.21037/jtd.2017.02.93. Search in Google Scholar